NUPHARM LIMITED
Get an alert when NUPHARM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-10-31 (in 5mo)
Last filed for 2025-01-31
Confirmation statement due
2026-09-26 (in 4mo)
Last made up 2025-09-12
Watchouts
None on the register
Cash
£2K
-96.1% vs 2024
Net assets
£12M
-76.2% vs 2024
Employees
88
-1.1% vs 2024
Profit before tax
£29M
-10.8% vs 2024
Name history
Renamed 1 time since incorporation
- NUPHARM LIMITED 2006-02-08 → present
- LINCOLN PHARMA LTD 2003-09-12 → 2006-02-08
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-01-31
| Metric | Trend | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Turnover | £410,119,000 | £440,416,000 | |
| Operating profit | £32,927,000 | £29,379,000 | |
| Profit before tax | £32,915,000 | £29,376,000 | |
| Net profit | £24,998,000 | £22,002,000 | |
| Cash | £51,000 | £2,000 | |
| Total assets less current liabilities | £49,898,000 | £11,914,000 | |
| Net assets | £49,868,000 | £11,870,000 | |
| Equity | £49,868,000 | £11,870,000 | |
| Average employees | 89 | 88 | |
| Wages | £2,582,000 | £2,745,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating margin | 8.0% | 6.7% | |
| Net margin | 6.1% | 5.0% | |
| Return on capital employed | 66.0% | 246.6% | |
| Gearing (liabilities / total assets) | 47.9% | 86.8% | |
| Current ratio | 2.07x | 1.14x | |
| Interest cover | 2743.92x | 9793.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of their assessment of the Company's financial position the Directors have a reasonable expectation that the Company will be able to continue in operational existence for the going concern period until 30 September 2026. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Significant events
- “Profit on ordinary activities before taxation has decreased by 10.8% to £29,376,000 (2024: £32,915,000) principally due to price suppression in the generics market and personnel cost inflation.”
- “The key financial risk is a significant change in foreign currency exchange rates.”
- “Government changes to the pharmacy remuneration structure, such as the Category M mechanism or adjustments to fees paid for dispensing services, have a direct impact on the profitability of one of the main customer categories of the business.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HOMAN, Alexander David Edward | Secretary | 2026-04-01 | — | — |
| ANDERSON, Stephen William | Director | 2017-10-01 | Sep 1966 | British |
| FEARN, Jonathan Lee | Director | 2024-02-01 | Apr 1974 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLAKEMAN, Michael Peter | Secretary | 2008-04-11 | 2019-03-10 |
| BURTON, Annabelle | Secretary | 2019-05-13 | 2020-12-23 |
| GOLOMBECK, Anthony | Secretary | 2003-10-17 | 2006-01-13 |
| GOULT, David Alexander | Secretary | 2006-01-13 | 2008-04-11 |
| MARKS, Stephen John William | Secretary | 2020-12-23 | 2026-03-31 |
| MEHTA, Ketan Himatlal | Secretary | 2003-10-17 | 2005-02-09 |
| @UKPLC CLIENT SECRETARY LTD | Corporate Nominee Secretary | 2003-09-12 | 2003-10-17 |
| BLACK, Kenneth John | Director | 2018-02-01 | 2019-05-31 |
| COLE, David Rowland | Director | 2006-01-13 | 2012-01-31 |
| GLYNN, Marshall Anthony | Director | 2005-02-09 | 2006-01-13 |
| GOLOMBECK, Anthony | Director | 2003-10-17 | 2006-01-13 |
| HUDSON, Kevin Robert | Director | 2006-01-13 | 2021-07-31 |
| MEHTA, Ketan Himatlal | Director | 2003-10-17 | 2005-02-09 |
| PFLUG, Stefan | Director | 2009-05-01 | 2012-04-06 |
| SMITH, Paul Jonathan | Director | 2008-04-01 | 2017-10-01 |
| WACHTER, Maximilian Martin | Director | 2020-12-01 | 2024-03-31 |
| @UKPLC CLIENT DIRECTOR LTD | Corporate Nominee Director | 2003-09-12 | 2003-10-17 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Jeremy David Meader | Individual | Significant influence | 2016-04-06 | Ceased 2023-01-31 |
| Mr John Angus Preston | Individual | Significant influence | 2016-04-06 | Ceased 2017-05-01 |
| Mr Jason Stuart Hollins | Individual | Significant influence | 2016-04-06 | Ceased 2016-08-24 |
| Mr Paul Jonathan Smith | Individual | Significant influence | 2016-04-06 | Ceased 2016-04-06 |
| Mr Kevin Robert Hudson | Individual | Significant influence | 2016-04-06 | Ceased 2016-04-06 |
| Mr Michael Peter Blakeman | Individual | Significant influence | 2016-04-06 | Ceased 2016-04-06 |
| Phoenix Healthcare Distribution Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 108 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-21 | CH03 | officers | Change person secretary company with change date | |
| 2026-04-13 | AP03 | officers | Appoint person secretary company with name date | |
| 2026-04-13 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-08 | AA | accounts | Accounts with accounts type full | |
| 2025-09-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-31 | AA | accounts | Accounts with accounts type full | |
| 2024-09-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-07 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-03 | AA | accounts | Accounts with accounts type full | |
| 2023-09-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-22 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-10-06 | AA | accounts | Accounts with accounts type full | |
| 2022-09-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-04 | CH01 | officers | Change person director company with change date | |
| 2021-10-03 | AA | accounts | Accounts with accounts type full | |
| 2021-09-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-08-13 | TM01 | officers | Termination director company with name termination date | |
| 2021-08-12 | CH01 | officers | Change person director company with change date | |
| 2021-01-04 | AP03 | officers | Appoint person secretary company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-01-31 vs 2024-01-31
-
Turnover
+7.4%
£410,119,000 £440,416,000
-
Cash
-96.1%
£51,000 £2,000
-
Net assets
-76.2%
£49,868,000 £11,870,000
-
Employees
-1.1%
89 88
-
Operating profit
-10.8%
£32,927,000 £29,379,000
-
Profit before tax
-10.8%
£32,915,000 £29,376,000
-
Wages
+6.3%
£2,582,000 £2,745,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers